Ga onbeperkt met Magzter GOLD
Krijg onbeperkte toegang tot meer dan 9000 tijdschriften, kranten en Premium-verhalen voor slechts
Poging GOUD - Vrij
Novo Nordisk debuts Ozempic at ₹2,200 a week
Mint Ahmedabad
|December 13, 2025
Danish drugmaker Novo Nordisk on Friday launched its blockbuster diabetes drug Ozempic in India, with a starting price of ₹2,200 per week.
For a four-week course, the entry 0.25mg dose will be priced at ₹8,800, positioning the drug squarely in the premium bracket for India’s fast-growing obesity and metabolic-health market.
The launch comes close on the heels of Wegovy, Novo's dedicated weight-loss injection, which entered the market in June.
Dit verhaal komt uit de December 13, 2025-editie van Mint Ahmedabad.
Abonneer u op Magzter GOLD voor toegang tot duizenden zorgvuldig samengestelde premiumverhalen en meer dan 9000 tijdschriften en kranten.
Bent u al abonnee? Aanmelden
MEER VERHALEN VAN Mint Ahmedabad
Mint Ahmedabad
Confront ‘jobless growth’: let us focus on middle-class expansion
India must reverse widening income and wealth gaps for the sake of sustainable economic growth
3 mins
May 29, 2026
Mint Ahmedabad
Vietnam, EU lift India’s seafood exports to record high
India has rapidly diversified its labour-intensive seafood exports after the US imposed punitive tariffs last year, with Vietnam, the European Union (EU), China, Russia, and Japan emerging as major growth drivers in 2025-26 (FY26).
1 min
May 29, 2026
Mint Ahmedabad
Siddaramaiah steps down as Karnataka CM
Congress leader claims ‘clean conscience’; move follows tussle with deputy CM D.K. Shivakumar
1 mins
May 29, 2026
Mint Ahmedabad
Bankers may pay a hefty price for their embrace of Claude AI
Some banks are already feeling the pinch as AI use gets expensive
3 mins
May 29, 2026
Mint Ahmedabad
Bajaj Fin to invest up to ₹2,000 cr in AI startups
Bajaj Finserv and other Bajaj Group companies will invest ₹1,500 crore-₹2,000 crore in artificial intelligence (AI) innovation startups over the next five years to bridge the gap in private sector funding of research in India.
1 min
May 29, 2026
Mint Ahmedabad
Most super investors recoup March losses
The West Asia conflict rattled Dalal Street earlier this year, but easing crude oil prices and a rebound in broad market sentiment over the past few weeks have helped several prominent investors recover the losses they suffered during the March selloff.
2 mins
May 29, 2026
Mint Ahmedabad
Policybazaar’s co-founders to sell ₹654 cr shares
The co-founders of PB Fintech Ltd are looking to sell shares worth as much as ₹654-crore (around $68 million) through a secondary market transaction on Friday, according to the terms of the deal, seen by Mint.
1 min
May 29, 2026
Mint Ahmedabad
Trai probes Airtel 5G slicing amid net neutrality concerns
Regulator sought clarity on Airtel’s use of “fast lane” technology for Priority Postpaid plans
2 mins
May 29, 2026
Mint Ahmedabad
Influenced: from just freelance hustles to corporate paychecks
For most of India’s content creators, odd jobs on the side are a reality.
2 mins
May 29, 2026
Mint Ahmedabad
India, S. Korea set for speedy upgrade of trade agreement
India and South Korea have agreed to accelerate negotiations to upgrade their bilateral trade pact while acknowledging concerns over New Delhi’s widening trade deficit with Seoul, according to an official statement issued after the latest round of talks, held in New Delhi.
1 min
May 29, 2026
Listen
Translate
Change font size